Home> Products> lower hypoglycemia risk

{ "products": [ { "_id": "6a5de55aa467a7e64774de83", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Teneligliptin 20mg,Pioglitazone 15mg & Metformin Hydrochloride (Sustained Release) 1000mg Tablets", "description": "TENELIGOLD PM 1000 brings together three antidiabetic agents — Teneligliptin 20 mg, Pioglitazone 15 mg, and Metformin Hydrochloride (Sustained Release) 1000 mg — in a single tablet built to support glycemic control in adults living with Type 2 Diabetes Mellitus (T2DM). Rather than relying on one pathway, this triple-action formula addresses blood glucose from several angles at once, offering a more rounded approach to sugar management.\n\nProduced under strict pharmaceutical quality benchmarks, TENELIGOLD PM 1000 works to sharpen the body's response to insulin, prompt insulin release in step with rising glucose, and rein in the liver's excess sugar output. It's typically brought into a treatment plan once lifestyle changes and single-drug therapy no longer keep blood sugar within target range.\n\nComposition\n\nEach sustained-release tablet delivers:\n\nTeneligliptin – 20 mg\nPioglitazone – 15 mg\nMetformin Hydrochloride (Sustained Release) – 1000 mg\n\nDosage Form: Sustained Release Tablets\n\nHow TENELIGOLD PM 1000 Works\n\nThis tablet pairs three well-known antidiabetic molecules so their effects complement one another.\n\n1. Teneligliptin 20 mg\n\nA DPP-4 inhibitor, Teneligliptin raises the body's incretin hormone activity, which in turn:\n\nTriggers insulin output only when glucose levels are elevated\nCurbs glucagon release\nFlattens the post-meal blood sugar rise\nKeeps hypoglycemia risk low\n\n2. Pioglitazone 15 mg\n\nBelonging to the Thiazolidinedione (TZD) family, Pioglitazone:\n\nSharpens the body's sensitivity to insulin\nHelps muscle tissue take up and use glucose more effectively\nCuts down insulin resistance\nAids sustained glycemic management over time\n\n3. Metformin SR 1000 mg\n\nA Biguanide-class agent, Metformin SR:\n\nSlows the liver's glucose output\nLimits how much glucose the intestines absorb\nBoosts insulin responsiveness\nDelivers steady blood sugar control across the day\n\nBecause it's released gradually, the sustained-release format is also gentler on the stomach than immediate-release versions.\n\nBenefits of TENELIGOLD PM 1000\n\nWell-Rounded Blood Sugar Control The three-pronged formula works to steady both fasting glucose and the spikes that follow meals.\n\nStronger HbA1c Improvement Used appropriately, this combination therapy may lower HbA1c more than a single-agent approach would.\n\nSharper Insulin Response Pioglitazone's role in easing insulin resistance means the insulin the body produces (or receives) does more work.\n\nSteady, All-Day Coverage Metformin SR's gradual release keeps blood sugar levels more consistent throughout the day.\n\nOne Tablet, Three Medicines Combining proven antidiabetic drugs into a single pill can make treatment simpler and support better adherence.\n\nA Foundation for Long-Term Care Sustained glycemic control, paired with healthy lifestyle habits, may help lower the risk of diabetes-related complications down the line.\n\nIndications\n\nTENELIGOLD PM 1000 is intended as an add-on to diet and exercise for improving blood sugar control in adults with Type 2 Diabetes Mellitus, particularly where a physician determines combination therapy is the right course.\n\nIt is not meant for Type 1 Diabetes Mellitus or diabetic ketoacidosis.\n\nKey Features\nTriple-combination antidiabetic tablet\nSustained-release Metformin component\nSupports both fasting and post-meal glucose control\nImproves insulin sensitivity\nEncourages glucose-responsive insulin release\nLowers hepatic glucose output\nOnce-daily dosing convenience, as prescribed\nManufactured to rigorous quality standards\nSuited to long-term diabetes management under medical guidance\nWho May Benefit?\n\nPhysicians may consider TENELIGOLD PM 1000 for adult T2DM patients who:\n\nContinue to have unmanaged blood sugar despite two-drug therapy\nNeed better HbA1c outcomes\nShow marked insulin resistance\nRequire broader glycemic coverage\nWould benefit from a sustained-release metformin option\n\nEvery treatment decision should be tailored by the prescribing doctor.\n\nDirections for Use\nTake exactly as directed by your physician.\nSwallow the tablet whole with water.\nNever crush, chew, or split the sustained-release tablet.\nTaking it with food is generally advised to ease stomach upset.\nPair the medicine with your prescribed diet and exercise plan for best results.\nPossible Side Effects\n\nAs with any medicine, TENELIGOLD PM 1000 can cause side effects, though not everyone will experience them.\n\nCommonly reported:\n\nNausea\nDiarrhea\nStomach discomfort\nHeadache\nSlight weight gain\nSwelling in the extremities (peripheral edema), linked mainly to pioglitazone\n\nLess common but serious:\n\nLactic acidosis (a metformin-related risk, more likely in vulnerable patients)\nWorsening heart failure (associated with pioglitazone in select patients)\nAllergic reactions\nAbnormal liver function\n\nSeek urgent medical care if severe weakness, breathing difficulty, chest pain, or ongoing abdominal pain develops.\n\nPrecautions\n\nTell your healthcare provider before starting TENELIGOLD PM 1000 if you have any of the following:\n\nKidney disease\nLiver disease\nHeart failure\nBladder cancer, present or past\nPancreatitis\nVitamin B12 deficiency\nSevere dehydration\nAn upcoming surgery or imaging test involving iodinated contrast dye\n\nRoutine checks of blood glucose, HbA1c, kidney function, liver function, and related markers are advised throughout treatment.\n\nStorage Instructions\nStore below 30°C.\nKeep away from moisture and direct sunlight.\nLeave in the original packaging.\nStore out of children's reach.\nWhy Choose TENELIGOLD PM 1000?\n\nTENELIGOLD PM 1000 brings three established antidiabetic medicines together in one sustained-release tablet, giving physicians a way to simplify a patient's regimen while still addressing multiple facets of Type 2 Diabetes. Through its complementary mechanisms, it offers a well-rounded route to blood sugar control for suitably selected adult patients under medical supervision.\n\nFrequently Asked Questions (FAQs)\n\nWhat is TENELIGOLD PM 1000 used for? It's prescribed to help manage Type 2 Diabetes Mellitus in adults whose blood sugar needs combination therapy alongside diet and exercise.\n\nIs TENELIGOLD PM 1000 meant to be taken every day? Yes, exactly as your physician prescribes. Don't adjust the dose on your own.\n\nCan TENELIGOLD PM 1000 lead to low blood sugar? Taken alone, the hypoglycemia risk is generally low, though it can rise if combined with insulin or sulfonylureas.\n\nCan I stop the medicine once my sugar levels normalize? No — diabetes is a long-term condition. Keep taking the medicine unless your doctor says otherwise.\n\nIs this medicine right for Type 1 Diabetes? No. It's formulated only for adults with Type 2 Diabetes Mellitus.\n\nShould TENELIGOLD PM 1000 be taken with food? Yes, taking it with meals is generally recommended to reduce stomach-related side effects.\n\nDoes it help bring down HbA1c? Yes — used as directed alongside lifestyle changes, it can support meaningful HbA1c improvement.\n\nPrescription only – consult your doctor.\n\n", "price": 385.0, "discountamount": 95.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2473, "imageuri": "https://productimages.withfloats.com/actual/6a5de55cdc76c6268e3fe287.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5de55cdc76c6268e3fe287.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T09:07:38.732Z", "updatedon": "2026-07-20T09:07:38.732Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligliptin-20mg-pioglitazone-15mg-metformin-hydrochloride-sustained-release-1000mg-tablets/2473", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PM 1000", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a1ec0fb574466f5ec21abe8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "description": "Generate unique content Seo geo friendly At least 1500 words humanizes and long and detailed articles on composition “ gliclazide and dapagliflozin combination\n\n” using brand name “ GLICLAGLAZE DAPA 60-10” use composition in heading “gliclazide and dapagliflozin combination ” and also use brand name Steris healthcare……. H1 How works……H2 Why its important …….H2 Key Benefits of ……….H3 What are the benefits …….H2 Side effects………H3 Serious Side Effects Of ……….H3 Available Substitute For ……….H2 Dosage Guidelines For …..H2 Precautions & Warnings: …..H2 with using and also Mechanism to action also with composition“gliclazide and dapagliflozin combination” Target Buyer intent INDICATIONS, EFFICACY AND CLINICAL EVIDENCE keywords”” : Conclusion: keep conclusion and Frequently Asked Questions 1 Is it safe to take gliclazide and dapagliflozin together? 2 What are the benefits of taking gliclazide and dapagliflozin concurrently? 3 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin? 4 Where can I find a doctor specializing in diabetes management who prescribes this combination? 5 Where can I buy gliclazide and dapagliflozin in one prescription? 6 Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nFor Further More Information: \n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +918824175417, +919982524671\n\nBuy Now\n\nBelow is SEO-friendly, GEO-optimized, buyer-intent content for your product page targeting “gliclazide and dapagliflozin combination” and branded as GLICLAGLAZE DAPA 60-10 from Steris Healthcare.\n\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\nGliclazide and Dapagliflozin Combination – Complete Guide to GLICLAGLAZE DAPA 60-10 by Steris Healthcare\n\nDiabetes mellitus is one of the most common chronic metabolic disorders affecting millions of people worldwide. Effective blood sugar management requires a comprehensive treatment approach that helps control glucose levels, reduce complications, and improve overall quality of life. The gliclazide and dapagliflozin combination has emerged as an effective therapeutic option for patients with Type 2 Diabetes Mellitus (T2DM) who require better glycemic control.\n\nGLICLAGLAZE DAPA 60-10, developed by Steris Healthcare, combines the proven efficacy of Gliclazide 60 mg Sustained Release and Dapagliflozin 10 mg to provide dual-action blood glucose control. This innovative combination works through complementary mechanisms to help diabetic patients achieve target blood sugar levels effectively.\n\nThis detailed guide covers the mechanism of action, indications, benefits, dosage guidelines, precautions, efficacy, clinical evidence, side effects, and frequently asked questions regarding the gliclazide and dapagliflozin combination.\n\nHow Gliclazide and Dapagliflozin Combination Works\n\nThe gliclazide and dapagliflozin combination utilizes two distinct yet complementary mechanisms to lower blood glucose levels.\n\nGliclazide Mechanism of Action\n\nGliclazide belongs to the sulfonylurea class of antidiabetic medications. It stimulates the pancreatic beta cells to release insulin, helping the body reduce elevated blood sugar levels.\n\nKey actions include:\n\nIncreases insulin secretion from the pancreas\nImproves glucose utilization\nReduces fasting blood glucose\nEnhances post-meal glucose control\nHelps maintain long-term glycemic stability\nDapagliflozin Mechanism of Action\n\nDapagliflozin belongs to the SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor class.\n\nIt works by:\n\nBlocking glucose reabsorption in the kidneys\nIncreasing glucose excretion through urine\nReducing blood sugar independently of insulin\nPromoting mild weight reduction\nSupporting cardiovascular and renal protection\nCombined Mechanism of Action\n\nWhen combined, Gliclazide and Dapagliflozin provide:\n\nIncreased insulin secretion\nReduced renal glucose reabsorption\nBetter fasting and postprandial glucose control\nLower HbA1c levels\nImproved metabolic outcomes\n\nThis dual-action approach makes GLICLAGLAZE DAPA 60-10 a highly effective treatment for Type 2 Diabetes Mellitus.\n\nWhy Its Important\n\nManaging diabetes effectively is essential to prevent serious complications such as:\n\nHeart disease\nStroke\nKidney damage\nNerve damage\nVision loss\nDiabetic foot complications\n\nThe gliclazide and dapagliflozin combination is important because it addresses multiple aspects of blood sugar regulation while offering additional metabolic and cardiovascular benefits.\n\nFor patients whose diabetes remains uncontrolled with single-drug therapy, combination treatment provides enhanced glucose management and improved treatment outcomes.\n\nKey Benefits of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 offers several significant benefits for diabetic patients.\n\nBetter Blood Sugar Control\n\nThe combination effectively lowers fasting and post-meal blood glucose levels.\n\nSignificant HbA1c Reduction\n\nClinical studies demonstrate meaningful reductions in HbA1c levels, helping patients achieve glycemic targets.\n\nWeight Management Support\n\nDapagliflozin promotes urinary glucose excretion, which may contribute to modest weight loss.\n\nReduced Risk of Diabetes Complications\n\nConsistent glycemic control lowers the risk of long-term diabetic complications.\n\nCardiovascular Benefits\n\nDapagliflozin has demonstrated cardiovascular protective effects in high-risk diabetic patients.\n\nRenal Protection\n\nThe medication supports kidney health and may slow progression of diabetic kidney disease.\n\nConvenient Once-Daily Dosing\n\nThe formulation enhances patient compliance through simple administration.\n\nWhat Are the Benefits of Gliclazide and Dapagliflozin Combination?\n\nPatients taking GLICLAGLAZE DAPA 60-10 may experience:\n\nImproved glycemic control\nBetter insulin utilization\nLower HbA1c values\nEnhanced metabolic function\nReduced fasting blood sugar\nBetter postprandial glucose management\nWeight management support\nImproved cardiovascular outcomes\nRenal protective effects\nIncreased treatment adherence\nIndications of Gliclazide and Dapagliflozin Combination\n\nGLICLAGLAZE DAPA 60-10 is indicated for:\n\nType 2 Diabetes Mellitus\n\nUsed in adults when diet, exercise, and monotherapy do not adequately control blood glucose.\n\nInadequate Glycemic Control\n\nRecommended for patients requiring intensified diabetes treatment.\n\nLong-Term Diabetes Management\n\nSupports sustained blood glucose control and prevention of complications.\n\nPatients with Cardiovascular Risk Factors\n\nMay provide additional cardiovascular benefits alongside glycemic management.\n\nEfficacy and Clinical Evidence\n\nSeveral clinical studies support the effectiveness of combining sulfonylureas such as Gliclazide with SGLT2 inhibitors like Dapagliflozin.\n\nHbA1c Reduction\n\nClinical trials demonstrate:\n\nSignificant reductions in HbA1c levels\nImproved fasting plasma glucose\nEnhanced postprandial glucose control\nWeight Reduction\n\nDapagliflozin contributes to calorie loss through urinary glucose excretion, leading to modest weight reduction.\n\nCardiovascular Outcomes\n\nResearch indicates that SGLT2 inhibitors may reduce hospitalization for heart failure and improve cardiovascular outcomes.\n\nRenal Outcomes\n\nStudies have shown benefits in slowing progression of diabetic kidney disease and improving renal function markers.\n\nThese findings make the gliclazide and dapagliflozin combination a valuable therapeutic option for comprehensive diabetes management.\n\nSide Effects of Gliclazide and Dapagliflozin Combination\n\nLike all medications, GLICLAGLAZE DAPA 60-10 may cause side effects.\n\nCommon side effects include:\n\nHeadache\nDizziness\nFrequent urination\nIncreased thirst\nNausea\nFatigue\nMild urinary tract infections\nGenital fungal infections\nLow blood sugar (hypoglycemia)\n\nMost side effects are mild and manageable.\n\nSerious Side Effects Of Gliclazide and Dapagliflozin Combination\n\nAlthough uncommon, serious side effects may include:\n\nSevere hypoglycemia\nDiabetic ketoacidosis\nSevere dehydration\nAcute kidney injury\nSerious urinary tract infections\nAllergic reactions\nSevere skin reactions\n\nSeek immediate medical attention if serious symptoms occur.\n\nAvailable Substitute For Gliclazide and Dapagliflozin Combination\n\nAlternative antidiabetic combinations may include:\n\nMetformin + Dapagliflozin\nSitagliptin + Dapagliflozin\nGliclazide + Metformin\nGlimepiride + Dapagliflozin\nEmpagliflozin-based combinations\n\nThe choice of therapy should always be determined by a healthcare professional based on individual patient needs.\n\nDosage Guidelines For Gliclazide and Dapagliflozin Combination\nRecommended Dose\n\nTake GLICLAGLAZE DAPA 60-10 exactly as prescribed by your physician.\n\nAdministration Instructions\nUsually taken once daily\nSwallow the tablet whole\nDo not crush or chew sustained-release tablets\nTake with or after food if advised\nMaintain adequate hydration\nMissed Dose\n\nIf a dose is missed:\n\nTake it as soon as remembered\nSkip if close to the next scheduled dose\nDo not double the dose\nOverdose\n\nSeek immediate medical attention in case of overdose.\n\nPrecautions & Warnings: Gliclazide and Dapagliflozin Combination\nMonitor Blood Sugar Regularly\n\nFrequent blood glucose monitoring helps optimize treatment outcomes.\n\nRisk of Hypoglycemia\n\nPatients should recognize symptoms such as:\n\nSweating\nTremors\nHunger\nConfusion\nDizziness\nMaintain Hydration\n\nDapagliflozin increases urinary glucose excretion and may increase fluid loss.\n\nKidney Function Monitoring\n\nRegular renal function assessments are recommended.\n\nLiver Function Monitoring\n\nPeriodic liver function evaluation may be necessary.\n\nPregnancy and Breastfeeding\n\nConsult a healthcare professional before use during pregnancy or lactation.\n\nAlcohol Consumption\n\nAlcohol may increase the risk of hypoglycemia and should be used cautiously.\n\nElderly Patients\n\nAdditional monitoring may be required due to increased sensitivity to treatment effects.\n\nWhy Choose GLICLAGLAZE DAPA 60-10 from Steris Healthcare?\n\nSteris Healthcare is committed to providing high-quality pharmaceutical products that support better patient outcomes.\n\nBenefits include:\n\nHigh manufacturing standards\nReliable quality assurance\nEffective diabetes management solution\nAdvanced combination therapy\nImproved patient compliance\nTrusted healthcare support\n\nGLICLAGLAZE DAPA 60-10 reflects Steris Healthcare’s dedication to innovation and excellence in diabetes care.\n\nConclusion\n\nThe gliclazide and dapagliflozin combination found in GLICLAGLAZE DAPA 60-10 offers a comprehensive and effective approach to Type 2 Diabetes Mellitus management. By combining the insulin-stimulating effects of Gliclazide with the glucose-excreting action of Dapagliflozin, this therapy provides superior blood sugar control, improved HbA1c reduction, cardiovascular support, renal protection, and enhanced patient convenience.\n\nFor patients seeking better glycemic control and long-term diabetes management, GLICLAGLAZE DAPA 60-10 from Steris Healthcare represents a scientifically supported and clinically effective treatment option.\n\nBuy Now\n\nFor product inquiries, bulk orders, franchise opportunities, and distribution partnerships:\n\nMail Us: contact@sterispharma.com or info@sterispharma.com\n\nCall Now: +91 8824175417, +91 9982524671\n\nBuy Now: Contact Steris Healthcare for product availability and ordering information.\n\nFrequently Asked Questions (FAQs)\n1. Is it safe to take gliclazide and dapagliflozin together?\n\nYes. Under medical supervision, the combination is considered safe and effective for managing Type 2 Diabetes Mellitus.\n\n2. What are the benefits of taking gliclazide and dapagliflozin concurrently?\n\nThe combination offers improved blood sugar control, HbA1c reduction, weight management support, cardiovascular benefits, and renal protection.\n\n3. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nMany retail pharmacies, hospital pharmacies, and authorized pharmaceutical distributors stock gliclazide and dapagliflozin combination products. Availability may vary by location.\n\n4. Where can I find a doctor specializing in diabetes management who prescribes this combination?\n\nEndocrinologists, diabetologists, and experienced physicians commonly prescribe this combination for Type 2 Diabetes management.\n\n5. Where can I buy gliclazide and dapagliflozin in one prescription?\n\nYou can obtain the medication through a valid prescription from a registered healthcare professional and purchase it from authorized pharmacies.\n\n6. Which pharmacies offer combined treatment options involving gliclazide and dapagliflozin?\n\nLicensed pharmacies, diabetes specialty centers, and authorized pharmaceutical distributors often provide combination antidiabetic therapies, including GLICLAGLAZE DAPA 60-10.\n\ncreate 3d image without changing product image\nEdit\ncreate 3d image without changing product image please regenerate again\nEdit\nThis is my product page H1 Title “ Benfotiamine Mecobalamin,Pyridoxine Hydrochloride Folic Acid,Inositol & Alpha Lipoic Acid Capsules” generate complete as a buyer intent reading content on this targted keyword. content must between 1000- 1200 words \nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules – Complete Guide for Nerve Health and Diabetic Neuropathy Support\n\nMaintaining healthy nerves is essential for overall well-being, especially for individuals living with diabetes, nutritional deficiencies, metabolic disorders, and nerve-related complications. Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are scientifically formulated to provide comprehensive nutritional support for nerve health, improve nerve function, and help manage symptoms associated with diabetic neuropathy and peripheral nerve disorders.\n\nThis advanced combination contains essential neurotropic vitamins and antioxidants that work together to nourish damaged nerves, improve nerve conduction, reduce oxidative stress, and support overall neurological health. These capsules are widely prescribed by healthcare professionals for patients experiencing tingling, numbness, burning sensations, nerve pain, and vitamin B deficiencies.\n\nWhether you are searching for an effective solution for diabetic neuropathy or looking to support long-term nerve health, Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules offer a comprehensive approach to neurological wellness.\n\nWhat Are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules?\n\nThese capsules combine six powerful ingredients known for their nerve-protective and restorative properties:\n\nBenfotiamine\nMecobalamin (Methylcobalamin)\nPyridoxine Hydrochloride (Vitamin B6)\nFolic Acid (Vitamin B9)\nInositol\nAlpha Lipoic Acid\n\nTogether, these ingredients help support healthy nerve function, improve metabolic processes, and protect nerve tissues from damage caused by oxidative stress and elevated blood sugar levels.\n\nHow Do Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules Work?\n\nThe effectiveness of this formulation lies in its multi-dimensional mechanism of action.\n\nBenfotiamine\n\nBenfotiamine is a fat-soluble derivative of Vitamin B1 that offers superior absorption.\n\nIt helps:\n\nProtect nerves from glucose-induced damage\nImprove nerve conductivity\nReduce diabetic complications\nSupport healthy metabolism\nMecobalamin\n\nMecobalamin is an active form of Vitamin B12 that plays a critical role in nerve regeneration.\n\nBenefits include:\n\nRepairing damaged nerve cells\nSupporting myelin sheath formation\nEnhancing nerve signal transmission\nReducing neuropathic symptoms\nPyridoxine Hydrochloride\n\nVitamin B6 supports neurological and metabolic functions.\n\nIt helps:\n\nMaintain healthy nerve cells\nImprove neurotransmitter production\nSupport brain and nervous system function\nFolic Acid\n\nFolic Acid contributes to:\n\nDNA synthesis\nRed blood cell production\nNerve cell development\nHomocysteine reduction\nInositol\n\nInositol assists in:\n\nNerve signaling pathways\nCellular communication\nMetabolic regulation\nNeurological function support\nAlpha Lipoic Acid\n\nAlpha Lipoic Acid is a potent antioxidant.\n\nIt helps:\n\nNeutralize free radicals\nReduce oxidative stress\nImprove nerve blood flow\nRelieve symptoms of diabetic neuropathy\nKey Benefits of Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nThis unique formulation offers multiple health benefits.\n\nSupports Nerve Regeneration\n\nThe combination promotes repair and regeneration of damaged nerve tissues.\n\nHelps Manage Diabetic Neuropathy\n\nMany diabetic patients experience:\n\nTingling sensations\nBurning feet\nNumbness\nSharp nerve pain\n\nThese capsules help manage such symptoms effectively.\n\nReduces Oxidative Stress\n\nAlpha Lipoic Acid protects nerves from oxidative damage caused by free radicals.\n\nImproves Nerve Conduction\n\nMecobalamin and Benfotiamine help restore healthy nerve signaling pathways.\n\nEnhances Energy Metabolism\n\nB-complex vitamins improve cellular energy production and metabolic efficiency.\n\nSupports Brain and Cognitive Function\n\nEssential vitamins support neurological health and mental performance.\n\nHelps Prevent Vitamin Deficiencies\n\nProvides important nutrients often deficient in diabetic and elderly patients.\n\nWhy Doctors Recommend Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules\n\nHealthcare professionals commonly prescribe this combination because it addresses the underlying nutritional and oxidative factors contributing to nerve damage.\n\nDoctors often recommend these capsules for:\n\nDiabetic neuropathy\nPeripheral neuropathy\nVitamin B12 deficiency\nNerve pain management\nNutritional supplementation\nNeurological disorders\nRecovery from nerve injuries\n\nThe synergistic action of these ingredients offers broader therapeutic benefits than single-nutrient supplements.\n\nIndications\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules are commonly indicated for:\n\nDiabetic Neuropathy\n\nHelps reduce symptoms associated with diabetes-related nerve damage.\n\nPeripheral Neuropathy\n\nSupports nerve health in patients experiencing nerve dysfunction.\n\nVitamin B Complex Deficiencies\n\nProvides nutritional support for individuals with inadequate vitamin intake.\n\nNerve Pain\n\nHelps manage neuropathic discomfort and sensory disturbances.\n\nMetabolic Neuropathy\n\nSupports patients affected by metabolic conditions impacting nerve function.\n\nNeurological Support\n\nUseful in maintaining healthy nervous system function.\n\nWho Should Consider These Capsules?\n\nThese capsules may benefit:\n\nIndividuals with diabetes\nPatients experiencing numbness or tingling\nElderly individuals with nerve weakness\nPeople recovering from neurological disorders\nIndividuals with vitamin B deficiencies\nPatients with chronic nerve pain\n\nA healthcare professional can determine if this supplement is appropriate based on individual medical needs.\n\nDosage and Administration\n\nAlways take Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules as directed by your healthcare provider.\n\nGeneral Guidelines\nUsually taken once daily or as prescribed\nSwallow the capsule whole with water\nPreferably taken after meals\nFollow the recommended dosage schedule\n\nDo not exceed the prescribed dose without medical advice.\n\nPossible Side Effects\n\nMost patients tolerate these capsules well. However, some individuals may experience mild side effects.\n\nCommon side effects may include:\n\nNausea\nStomach discomfort\nMild headache\nDizziness\nBloating\nSkin rash\nAllergic reactions\n\nThese side effects are generally temporary and manageable.\n\nPrecautions and Warnings\n\nBefore taking these capsules, consider the following precautions:\n\nConsult Your Doctor If You Have:\nKidney disease\nLiver disorders\nSevere diabetes complications\nAllergies to any ingredient\nPregnancy and Breastfeeding\n\nUse only under medical supervision during pregnancy and lactation.\n\nDrug Interactions\n\nInform your doctor about:\n\nAntidiabetic medications\nAnticonvulsants\nVitamin supplements\nPrescription medications\nRegular Monitoring\n\nPatients with diabetes should continue monitoring blood glucose levels as advised.\n\nWhy Choose This Advanced Nerve Health Formula?\n\nThe combination of Benfotiamine, Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol, and Alpha Lipoic Acid provides comprehensive support through multiple mechanisms.\n\nKey advantages include:\n\nMulti-nutrient nerve support\nEnhanced antioxidant protection\nImproved nerve regeneration\nBetter diabetic neuropathy management\nConvenient single-capsule formulation\nLong-term neurological health benefits\n\nThis makes it an excellent choice for individuals seeking a scientifically formulated nerve support supplement.\n\nConclusion\n\nBenfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules represent a comprehensive solution for supporting nerve health, managing diabetic neuropathy, and addressing nutritional deficiencies that affect neurological function. The synergistic combination of neurotropic vitamins and powerful antioxidants helps repair damaged nerves, improve nerve conduction, reduce oxidative stress, and promote overall neurological wellness.\n\nFor individuals experiencing nerve pain, numbness, tingling sensations, or diabetic neuropathy symptoms, these capsules offer an effective and clinically trusted option. When used under medical supervision, they can play a valuable role in maintaining healthy nerve function and improving quality of life.\n\nFrequently Asked Questions (FAQs)\n1. What are Benfotiamine Mecobalamin, Pyridoxine Hydrochloride, Folic Acid, Inositol & Alpha Lipoic Acid Capsules used for?\n\nThey are primarily used to support nerve health, manage diabetic neuropathy, and treat vitamin B deficiencies.\n\n2. Can these capsules help with diabetic neuropathy?\n\nYes. The combination is commonly prescribed to help reduce symptoms such as tingling, numbness, burning sensations, and nerve pain associated with diabetic neuropathy.\n\n3. How long does it take to see results?\n\nResults vary depending on the severity of nerve damage and individual health conditions. Consistent use as prescribed is important.\n\n4. Are these capsules safe for long-term use?\n\nWhen taken under medical supervision, they are generally considered safe for long-term nutritional and neurological support.\n\n5. Can non-diabetic patients take these capsules?\n\nYes. They may also be prescribed for vitamin deficiencies, peripheral neuropathy, and other nerve-related conditions.\n\n6. Do these capsules require a prescription?\n\nAvailability may vary by region, but it is always recommended to use them under the guidance of a healthcare professional.", "price": 390.0, "discountamount": 117.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2435, "imageuri": "https://productimages.withfloats.com/actual/6a1ec0fefe6140386d7a9074.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1ec0fefe6140386d7a9074.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-02T11:39:39.761Z", "updatedon": "2026-06-04T07:08:32.501Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//benfotiamine-mecobalamin-pyridoxine-hydrochloride-folic-acid-inositol-alpha-lipoic-acid-capsules/2435", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NUTRIDIAB PN", "category": "NEUROLOGY RANGE", "tags": [ "Benfotiamine,Mecobalamin,Pyridoxine Hydrochloride,Folic Acid,Inositol & Alpha Lipoic Acid Capsules", "Methylcobalamin alpha lipoic acid Pyridoxine Folic Acid Benfotiamine", "Benfotiamine Mecobalamin Pyridoxine Hydrochloride Folic Acid Inositol Alpha Lipoic Acid Capsules", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Buy Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules Online", "Diabetic Neuropathy Treatment Capsules", "Benfotiamine and Mecobalamin Capsules for Nerve Pain", "Alpha Lipoic Acid Capsules for Diabetic Neuropathy", "Vitamin B Complex and Alpha Lipoic Acid Capsules", "Benfotiamine Mecobalamin Capsules Product Image", "Best Capsules for Diabetic Nerve Damage", "Nerve Regeneration and Nerve Support Capsules", "Vitamin B12 and Alpha Lipoic Acid Capsules", "Nerve Strengthening Capsules with Benfotiamine", "Benfotiamine Mecobalamin Alpha Lipoic Acid Capsules for Neuropathy" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69d6115048622857aafcb373", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "sitagliptin 50 mg + dapagliflozin 5 mg", "description": "Managing type 2 diabetes effectively requires a balanced approach that includes medication, diet, and lifestyle changes. ST-Gliptin Dapa, a powerful dual-combination therapy containing Dapagliflozin 5 mg and Sitagliptin Phosphate 50 mg, is designed to provide effective glycemic control for adults suffering from type 2 diabetes mellitus.\n\nThis innovative formulation works through two complementary mechanisms to help regulate blood sugar levels, reduce glucose reabsorption, and improve insulin response, making it a reliable choice for patients who need combination therapy.\n\nHow ST-Gliptin Dapa Works\n\nST-Gliptin Dapa combines two well-established antidiabetic agents that target different pathways in glucose metabolism:\n\nDapagliflozin belongs to the SGLT2 inhibitor class. It works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. This helps lower blood sugar levels and also supports mild weight loss.\nSitagliptin phosphate is a DPP-4 inhibitor that increases incretin hormone levels. These hormones help stimulate insulin release after meals and reduce glucagon secretion, leading to better postprandial glucose control.\n\nTogether, these two medications provide comprehensive blood sugar control throughout the day, especially in patients who are not achieving adequate results with a single drug.\n\nUses of ST-Gliptin Dapa\n\nST-Gliptin Dapa is prescribed for the following:\n\nManagement of Type 2 Diabetes Mellitus\nPatients with inadequate control on monotherapy\nReducing fasting and post-meal blood glucose levels\nImproving insulin secretion and sensitivity\nSupporting overall metabolic balance\n\nIt is usually recommended along with a proper diet and regular physical activity to achieve optimal results.\n\nKey Benefits of ST-Gliptin Dapa\n1. Dual Mechanism for Better Control\n\nThis combination works on both kidney and hormonal pathways, ensuring effective and sustained glucose reduction.\n\n2. Improved Glycemic Stability\n\nHelps reduce both fasting and postprandial blood sugar spikes, offering balanced control throughout the day.\n\n3. Weight Management Support\n\nDapagliflozin promotes glucose excretion, which can lead to modest weight loss, beneficial for overweight diabetic patients.\n\n4. Low Risk of Hypoglycemia\n\nCompared to insulin or sulfonylureas, this combination has a lower risk of causing hypoglycemia, making it safer for long-term use.\n\n5. Cardiovascular and Renal Benefits\n\nSGLT2 inhibitors like dapagliflozin are known to provide additional benefits for heart and kidney health when used under medical supervision.\n\n6. Enhanced Patient Compliance\n\nA fixed-dose combination reduces pill burden, making it easier for patients to follow their treatment plan consistently.\n\nDosage and Administration\nTake ST-Gliptin Dapa as prescribed by your healthcare provider\nTypically taken once daily, with or without food\nSwallow the tablet whole with water\nDo not skip doses or double up if a dose is missed\n\nAlways follow your doctor’s instructions for dosage adjustments based on your condition.\n\nSide Effects of ST-Gliptin Dapa\n\nLike all medications, ST-Gliptin Dapa may cause some side effects. Most are mild and manageable.\n\nCommon Side Effects\nFrequent urination\nThirst or dehydration\nHeadache\nNasopharyngitis (cold-like symptoms)\nMild gastrointestinal discomfort\nSerious Side Effects (Rare)\nUrinary tract infections\nGenital fungal infections\nPancreatitis (associated with DPP-4 inhibitors)\nKidney function changes\nSevere allergic reactions\n\nIf you experience any unusual or severe symptoms, seek medical attention immediately.\n\nPrecautions and Warnings\nNot recommended for patients with severe kidney impairment\nUse cautiously in elderly patients\nMaintain proper hydration to avoid dehydration\nInform your doctor about any existing liver, kidney, or heart conditions\nAvoid excessive alcohol consumption\n\nPregnant and breastfeeding women should consult a doctor before using this medication.\n\nWho Should Use ST-Gliptin Dapa?\n\nThis medication is suitable for:\n\nAdults diagnosed with Type 2 Diabetes\nPatients needing dual therapy for better control\nIndividuals who are overweight or have insulin resistance\nPatients who are not achieving targets with a single medication\nStorage Instructions\nStore in a cool and dry place\nKeep away from direct sunlight and moisture\nKeep out of reach of children\nConclusion\n\nST-Gliptin Dapa is a modern and effective dual-combination therapy that offers a comprehensive solution for managing type 2 diabetes. With the combined action of Dapagliflozin 5 mg and Sitagliptin Phosphate 50 mg, it targets multiple pathways involved in glucose regulation, helping patients achieve better glycemic control.", "price": 290.0, "discountamount": 87.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2370, "imageuri": "https://productimages.withfloats.com/actual/69d61153b9380b73ede65348.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/69d61153b9380b73ede65348.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-08T08:26:56.108Z", "updatedon": "2026-05-04T10:05:22.561Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-50-mg-dapagliflozin-5-mg/2370", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST- GLIPTIN DAPA 50/5", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin sitagliptin phosphate tablets", "dapagliflozin sitagliptin phosphate", "Sitagliptin 50 Mg + Dapagliflozin 5 Mg", "dapagliflozin 5 mg sitagliptin 50 mg uses", "Sitagliptin 50 Mg + Dapagliflozin 5 Mg side effects", "dapagliflozin 5 mg sitagliptin 50 mg price in india", "buy sitagliptin 50 mg dapagliflozin 5 mg tablets", "sitagliptin dapagliflozin tablets wholesale price", "sitagliptin 50 mg + dapagliflozin 5 mg tablets", "dapagliflozin sitagliptin tablets bulk order" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69a9837a9c219e2cff873568", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dapagliflozin glimepiride metformin tablet", "description": "Composition: Dapagliflozin 10 mg + Glimepiride 2 mg + Metformin Hydrochloride 500 mg (Extended Release)\n\nManaging type 2 diabetes requires a balanced approach that includes proper medication, healthy lifestyle choices, and regular monitoring of blood sugar levels. Modern diabetes management often involves combination therapies that target blood glucose control through multiple mechanisms. One such effective combination medicine is GLIDAPAFLOZIN TRIO 2.\n\nThis medication contains three well-known antidiabetic agents—Dapagliflozin, Glimepiride, and Metformin Hydrochloride in an extended-release formulation. Together, these medicines work in different ways to help control blood sugar levels effectively in adults with type 2 diabetes.\n\nThis article provides a comprehensive overview of the product, its uses, benefits, possible side effects, and important information patients should know before using it.\n\nProduct Overview\n\nGLIDAPAFLOZIN TRIO 2 is a triple-combination oral antidiabetic tablet designed to help manage blood glucose levels in patients diagnosed with Type 2 Diabetes.\n\nEach tablet contains:\n\nDapagliflozin 10 mg\n\nGlimepiride 2 mg\n\nMetformin Hydrochloride 500 mg (Extended Release)\n\nThese ingredients work together to reduce high blood sugar levels through complementary mechanisms, helping patients achieve better glycemic control.\n\nCombination therapy like this is commonly recommended when a single medication alone is not sufficient to manage blood glucose levels.\n\nHow the Medicine Works\n\nThe three active ingredients in GLIDAPAFLOZIN TRIO 2 work through different pathways in the body.\n\n1. Dapagliflozin\n\nDapagliflozin belongs to a class of drugs known as SGLT2 inhibitors. It works by helping the kidneys remove excess glucose from the body through urine. This reduces blood sugar levels and may also provide additional cardiovascular and kidney benefits in some patients.\n\n2. Glimepiride\n\nGlimepiride stimulates the pancreas to release more insulin. Insulin is the hormone responsible for moving glucose from the bloodstream into cells where it can be used as energy.\n\n3. Metformin Hydrochloride (Extended Release)\n\nMetformin Hydrochloride helps lower blood sugar by reducing glucose production in the liver and improving insulin sensitivity in the body. The extended-release formulation ensures a steady release of the medicine over time, improving tolerance and effectiveness.\n\nTogether, these three medicines provide a comprehensive approach to blood sugar management.\n\nUses of GLIDAPAFLOZIN TRIO 2\n\nGLIDAPAFLOZIN TRIO 2 is primarily prescribed for the management of Type 2 Diabetes in adults.\n\nMain Uses\n\nBlood Sugar Control\nThe medication helps reduce high blood glucose levels in patients whose diabetes is not adequately controlled with diet, exercise, or single-drug therapy.\n\nImproving Insulin Function\nIt improves the body’s response to insulin and helps regulate glucose metabolism.\n\nPreventing Diabetes Complications\nProper blood sugar control reduces the risk of long-term complications such as nerve damage, kidney disease, vision problems, and cardiovascular issues.\n\nSupporting Weight and Metabolic Health\nThe presence of dapagliflozin may help some patients experience mild weight reduction and improved metabolic balance.\n\nKey Benefits\n\nThe combination of three effective antidiabetic agents offers several important benefits.\n\n1. Triple Mechanism Action\n\nThe medicine works through three complementary mechanisms, targeting multiple causes of high blood sugar.\n\n2. Better Glycemic Control\n\nPatients often achieve improved HbA1c levels compared to single-drug therapy.\n\n3. Reduced Risk of Long-Term Complications\n\nMaintaining controlled blood sugar levels helps prevent complications associated with diabetes.\n\n4. Convenient Single Tablet Therapy\n\nInstead of taking multiple medicines separately, patients can manage their treatment with a single tablet, improving medication adherence.\n\n5. Extended Release Technology\n\nThe extended-release formulation of Metformin Hydrochloride ensures gradual drug release, reducing stomach discomfort and improving patient tolerance.\n\n6. Improved Energy and Daily Functioning\n\nProper blood sugar control helps patients feel more energetic and maintain better overall health.\n\nPossible Side Effects\n\nLike all medications, GLIDAPAFLOZIN TRIO 2 may cause some side effects. However, not everyone experiences them.\n\nCommon Side Effects\n\nMild stomach discomfort\n\nNausea or vomiting\n\nDiarrhea\n\nHeadache\n\nIncreased urination\n\nLow blood sugar (hypoglycemia), especially when meals are skipped\n\nLess Common Side Effects\n\nUrinary tract infections\n\nDizziness or weakness\n\nMild dehydration\n\nRare but Serious Effects\n\nSevere hypoglycemia\n\nLactic acidosis (very rare but serious condition linked with metformin)\n\nAllergic reactions\n\nPatients should immediately consult a healthcare professional if they experience unusual symptoms such as severe weakness, difficulty breathing, or persistent stomach pain.\n\nPrecautions and Safety Advice\n\nBefore starting GLIDAPAFLOZIN TRIO 2, patients should inform their doctor if they have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of severe dehydration\n\nAny known drug allergies\n\nPatients should also avoid skipping meals and maintain proper hydration to reduce the risk of low blood sugar.\n\nRegular monitoring of blood glucose levels is important while using this medication.\n\nLifestyle Tips for Better Results\n\nMedication alone cannot control diabetes. Patients should combine treatment with healthy habits.\n\nRecommended lifestyle practices include:\n\nMaintaining a balanced diabetic diet\n\nExercising regularly\n\nMonitoring blood sugar levels\n\nAvoiding excessive sugar and processed foods\n\nManaging stress levels\n\nGetting sufficient sleep\n\nThese lifestyle changes enhance the effectiveness of diabetes medications.\n\nConclusion\nManaging diabetes requires a consistent and comprehensive approach. Combination medicines like GLIDAPAFLOZIN TRIO 2 provide an effective solution for patients who need stronger glucose control than single-drug therapy can offer.", "price": 184.0, "discountamount": 56.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2317, "imageuri": "https://productimages.withfloats.com/actual/69a9837cad119d5b47141190.png", "tileimageuri": "https://productimages.withfloats.com/tile/69a9837cad119d5b47141190.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-05T13:22:02.718Z", "updatedon": "2026-03-13T11:05:08.762Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapagliflozin-glimepiride-metformin-tablet/2317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN TRIO 2", "category": "DIABETIC RANGE", "tags": [ "dapagliflozin glimepiride metformin tablet uses and dosage", "dapagliflozin glimepiride metformin combination tablet benefits", "dapagliflozin glimepiride metformin tablet side effects in adults", "dapagliflozin glimepiride metformin tablet how it works", "dapagliflozin glimepiride metformin tablet benefits for sugar control", "buy dapagliflozin glimepiride metformin tablet online", "dapagliflozin glimepiride metformin tablet price in india", "dapagliflozin glimepiride metformin tablet for uncontrolled diabetes", "dapagliflozin glimepiride metformin tablet triple therapy medicine", "dapagliflozin glimepiride metformin tablet dosage guide for adults" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "699bfe45e844b0fb29d2bbad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 100 Pioglitazone 15 Metformin 500", "description": "Product Name: ST GLIPTIN 3D 500\nComposition: Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg\n\nST GLIPTIN 3D 500 is a scientifically formulated triple-combination oral antidiabetic tablet designed to help manage Type 2 Diabetes Mellitus effectively. This advanced formulation combines the proven benefits of Sitagliptin, Pioglitazone, and Metformin to provide comprehensive glycemic control through three complementary mechanisms of action.\n\nThis triple therapy approach is especially beneficial for patients whose blood glucose levels are not adequately controlled with dual therapy or monotherapy. ST GLIPTIN 3D 500 is developed to address multiple metabolic defects associated with Type 2 diabetes, ensuring better long-term glucose management and improved patient outcomes.\n\nProduct Description\n\nST GLIPTIN 3D 500 is an oral antidiabetic medication that works by targeting different physiological pathways involved in glucose regulation:\n\nSitagliptin 100 mg enhances incretin hormone levels, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner.\n\nPioglitazone 15 mg improves insulin sensitivity in muscle and adipose tissues, allowing the body to use insulin more effectively.\n\nMetformin 500 mg reduces hepatic glucose production and improves peripheral glucose uptake.\n\nBy combining these three well-established agents into a single tablet, ST GLIPTIN 3D 500 simplifies diabetes management while improving adherence and therapeutic efficiency.\n\nUses of ST GLIPTIN 3D 500\n\nST GLIPTIN 3D 500 is primarily indicated for:\n\nManagement of Type 2 Diabetes Mellitus\n\nImproving glycemic control in adults\n\nPatients inadequately controlled on metformin alone\n\nIndividuals requiring triple oral therapy\n\nReducing fasting and postprandial blood glucose levels\n\nSupporting long-term HbA1c reduction\n\nIt is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and weight management.\n\nHow ST GLIPTIN 3D 500 Works\n\nType 2 diabetes is characterized by insulin resistance, decreased insulin secretion, and excessive hepatic glucose production. ST GLIPTIN 3D 500 addresses all three core defects:\n\nEnhances insulin secretion (Sitagliptin) – Works in a glucose-dependent manner, reducing risk of hypoglycemia.\n\nImproves insulin sensitivity (Pioglitazone) – Helps the body respond better to insulin.\n\nReduces glucose production (Metformin) – Decreases sugar release from the liver.\n\nThis comprehensive mechanism makes ST GLIPTIN 3D 500 a powerful therapeutic option for sustained glycemic control.\n\nKey Benefits of ST GLIPTIN 3D 500\n1. Triple Mechanism Advantage\n\nCombines three different classes of antidiabetic agents for broader and more effective blood sugar management.\n\n2. Improved HbA1c Reduction\n\nHelps significantly lower HbA1c levels when compared to monotherapy.\n\n3. Reduced Pill Burden\n\nThree medications in one tablet improve patient compliance and convenience.\n\n4. Better Postprandial Control\n\nHelps manage blood glucose spikes after meals.\n\n5. Insulin Sensitivity Enhancement\n\nPioglitazone improves peripheral glucose utilization.\n\n6. Lower Risk of Hypoglycemia\n\nSitagliptin works in a glucose-dependent manner, minimizing low blood sugar risk when used appropriately.\n\n7. Suitable for Long-Term Management\n\nDesigned for chronic use under medical supervision.\n\nDosage and Administration\n\nThe dosage should be taken strictly as prescribed by a healthcare professional.\n\nUsually administered once daily with meals to reduce gastrointestinal discomfort.\n\nSwallow the tablet whole with water.\n\nDo not crush or chew unless directed by a doctor.\n\nRegular monitoring of blood glucose and HbA1c levels is recommended during therapy.\n\nPossible Side Effects\n\nLike all medications, ST GLIPTIN 3D 500 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nUpper respiratory symptoms\n\nLess Common but Important:\n\nWeight gain (associated with Pioglitazone)\n\nFluid retention or edema\n\nLow blood sugar (when combined with other antidiabetic agents)\n\nVitamin B12 deficiency (long-term Metformin use)\n\nRare but Serious:\n\nLactic acidosis (rare, associated with Metformin)\n\nPancreatitis (rare, associated with Sitagliptin)\n\nLiver function abnormalities\n\nPatients should immediately consult a healthcare provider if they experience severe abdominal pain, persistent vomiting, unusual swelling, or breathing difficulties.\n\nPrecautions and Warnings\n\nNot recommended for Type 1 diabetes.\n\nUse cautiously in patients with renal impairment.\n\nLiver function monitoring may be required.\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about any existing heart conditions.\n\nPregnant or breastfeeding women should use this medication only if clearly advised by a healthcare professional.\n\nStorage Instructions\n\nStore below 25°C in a dry place.\n\nKeep away from direct sunlight.\n\nKeep out of reach of children.\n\nWhy Choose ST GLIPTIN 3D 500?\n\nST GLIPTIN 3D 500 stands out as a comprehensive diabetes management solution by combining three powerful and clinically established molecules in one convenient tablet. It is particularly beneficial for patients who require intensified glycemic control without increasing pill burden.\n\nThe triple therapy model helps target multiple metabolic dysfunctions simultaneously, offering better blood glucose stability throughout the day. When used as part of a complete diabetes management plan—including diet, exercise, and routine monitoring—ST GLIPTIN 3D 500 can significantly enhance quality of life and reduce long-term complications associated with uncontrolled diabetes.\n\nConclusion\nST GLIPTIN 3D 500 (Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg) represents a modern, evidence-based approach to managing Type 2 Diabetes Mellitus. By addressing insulin resistance, impaired insulin secretion, and excessive glucose production, it provides comprehensive and sustained glycemic control.", "price": 222.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2311, "imageuri": "https://productimages.withfloats.com/actual/699bfe47d849febb9bcc2d46.png", "tileimageuri": "https://productimages.withfloats.com/tile/699bfe47d849febb9bcc2d46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-23T07:14:13.494Z", "updatedon": "2026-03-13T11:04:02.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100-pioglitazone-15-metformin-500/2311", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 3D 500", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 100 Pioglitazone 15 Metformin 500 tablet uses", "Sitagliptin Pioglitazone Metformin triple therapy dosage", "Sitagliptin 100 mg Pioglitazone 15 mg Metformin 500 mg benefits", "Triple combination tablet for type 2 diabetes control", "Sitagliptin Pioglitazone Metformin side effects in adults", "How to take Sitagliptin Pioglitazone Metformin tablet", "Sitagliptin Metformin Pioglitazone price in India", "Buy Sitagliptin 100 Pioglitazone 15 Metformin 500 online", "Order Sitagliptin Pioglitazone Metformin tablets", "Sitagliptin 100 Pioglitazone 15 Metformin 500 price", "Sitagliptin triple combination bulk purchase" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6961f2c52800555f6696ac8f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate 100 mg", "description": "GLISITAPTIN 100 is a pharmaceutical formulation containing Sitagliptin Phosphate 100 mg as its active ingredient. This medication represents a significant advancement in the management of type 2 diabetes mellitus, offering patients an effective oral treatment option that works through an innovative mechanism of action. As part of the DPP-4 inhibitor class of antidiabetic medications, GLISITAPTIN 100 has emerged as a trusted choice for healthcare providers and patients seeking reliable glycemic control with a favorable safety profile.\nThe brand name GLISITAPTIN 100 signifies quality, efficacy, and a commitment to helping individuals with type 2 diabetes achieve better health outcomes. Each tablet is precisely formulated to deliver the optimal therapeutic dose of sitagliptin phosphate, ensuring consistent and predictable results in blood sugar management.\nUnderstanding Sitagliptin Phosphate\nSitagliptin phosphate is a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor that has revolutionized diabetes treatment since its introduction. Unlike older diabetes medications that work through insulin secretion or glucose absorption mechanisms alone, sitagliptin operates through the incretin system—a natural bodily process that regulates blood glucose levels in response to food intake.\nThe 100 mg strength available in GLISITAPTIN 100 represents the standard therapeutic dose for most adult patients, providing optimal efficacy while maintaining an excellent safety margin. This once-daily formulation simplifies treatment regimens and promotes better adherence, which is crucial for long-term diabetes management success.\nHow GLISITAPTIN 100 Works\nGLISITAPTIN 100 works through a sophisticated yet elegant mechanism that harnesses your body's natural glucose regulation system. When you eat, your intestines release hormones called incretins, specifically GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These incretins have multiple beneficial effects: they stimulate insulin secretion from the pancreas, suppress glucagon release (which reduces glucose production by the liver), and slow gastric emptying.\nHowever, these beneficial incretins are rapidly broken down by an enzyme called DPP-4, limiting their glucose-lowering effects. GLISITAPTIN 100 inhibits this DPP-4 enzyme, allowing incretins to remain active in your bloodstream for longer periods. This results in better insulin secretion when blood glucose is elevated, reduced glucagon levels, and ultimately improved blood sugar control throughout the day.\nImportantly, because this mechanism is glucose-dependent, GLISITAPTIN 100 primarily works when blood sugar is elevated, which significantly reduces the risk of hypoglycemia (dangerously low blood sugar) compared to some other diabetes medications.\nPrimary Uses and Indications\nType 2 Diabetes Mellitus Management: GLISITAPTIN 100 is primarily indicated for improving glycemic control in adult patients with type 2 diabetes mellitus. It can be prescribed as:\n\nMonotherapy: As a first-line treatment for patients who cannot achieve adequate control through diet and exercise alone, particularly when metformin is contraindicated or not tolerated\nCombination Therapy: Alongside metformin, sulfonylureas, thiazolidinediones, or insulin when these medications alone do not provide sufficient glucose control\nTriple Therapy: In combination with two other antidiabetic agents when dual therapy fails to achieve target HbA1c levels\n\nThe medication is particularly suitable for patients who require effective glucose control but have concerns about weight gain or hypoglycemia, as GLISITAPTIN 100 is weight-neutral and has a low hypoglycemia risk when used as monotherapy.\nKey Benefits of GLISITAPTIN 100\n1. Effective Glycemic Control\nClinical studies have demonstrated that GLISITAPTIN 100 significantly reduces HbA1c levels (a measure of long-term blood sugar control) by approximately 0.5-1.0%, helping patients achieve and maintain target glucose levels. This improvement translates to reduced risk of diabetes-related complications over time.\n2. Low Hypoglycemia Risk\nUnlike sulfonylureas or insulin, GLISITAPTIN 100 has a glucose-dependent mechanism, meaning it primarily works when blood sugar is elevated. This dramatically reduces the risk of hypoglycemic episodes, providing patients with greater safety and peace of mind, especially important for elderly patients or those with unpredictable meal schedules.\n3. Weight Neutral\nGLISITAPTIN 100 does not cause weight gain, a significant advantage over some other diabetes medications like insulin, sulfonylureas, or thiazolidinediones. Maintaining a healthy body weight is crucial for overall diabetes management and cardiovascular health.\n4. Once-Daily Convenience\nThe single daily dose requirement of GLISITAPTIN 100 simplifies treatment regimens, making it easier for patients to maintain adherence. Better adherence directly correlates with improved glycemic control and better long-term outcomes.\n5. Pancreatic Preservation\nBy working through the incretin system, GLISITAPTIN 100 may help preserve pancreatic beta-cell function, potentially slowing the progression of type 2 diabetes. This represents a significant long-term benefit beyond simple glucose control.\n6. Cardiovascular Safety\nClinical trials have demonstrated cardiovascular safety with sitagliptin, an important consideration given that cardiovascular disease is the leading cause of morbidity and mortality in patients with type 2 diabetes.\n7. Renal Dosing Available\nWhile the 100 mg dose is standard, sitagliptin can be adjusted for patients with kidney impairment, making it accessible to a broader patient population, including those with diabetic nephropathy.\n8. Well-Tolerated\nGLISITAPTIN 100 generally has a favorable side effect profile, with most patients experiencing minimal adverse effects, contributing to better quality of life during treatment.\nDosage and Administration\nThe standard recommended dose of GLISITAPTIN 100 is one tablet taken orally once daily, with or without food. The medication can be taken at any time of day, though taking it at the same time daily helps establish a routine and ensures consistent blood levels.\nFor patients with moderate to severe kidney disease, dosage adjustments may be necessary. Your healthcare provider will determine the appropriate dose based on your kidney function tests. It's crucial to follow your doctor's instructions precisely and not adjust your dose without medical guidance.\nPotential Side Effects\nWhile GLISITAPTIN 100 is generally well-tolerated, like all medications, it may cause side effects in some individuals:\nCommon Side Effects (Affecting 1-10% of patients):\n\nUpper respiratory tract infections\nNasopharyngitis (common cold symptoms)\nHeadache\nNausea\nAbdominal pain\nDiarrhea\n\nThese side effects are typically mild and often resolve on their own as your body adjusts to the medication.\nLess Common but Serious Side Effects:\n\nPancreatitis: Severe abdominal pain that may radiate to the back, with or without vomiting, requires immediate medical attention\nSevere Joint Pain: Persistent, severe joint pain has been reported in some patients; inform your doctor if this occurs\nAllergic Reactions: Rare cases of serious allergic reactions including anaphylaxis, angioedema, and severe skin reactions have occurred\nHeart Failure: In patients with existing heart disease, worsening heart failure has been reported\nBullous Pemphigoid: A rare skin condition requiring discontinuation of the medication\n\nWhen Used with Other Diabetes Medications:\nWhen GLISITAPTIN 100 is combined with sulfonylureas or insulin, the risk of hypoglycemia increases. Your doctor may reduce the dose of these medications when adding GLISITAPTIN 100 to your regimen.\nPrecautions and Contraindications\nDo Not Use GLISITAPTIN 100 if:\n\nYou are allergic to sitagliptin or any ingredients in the formulation\nYou have type 1 diabetes or diabetic ketoacidosis\nYou are under 18 years of age (safety and efficacy not established)\n\nUse with Caution if:\n\nYou have a history of pancreatitis\nYou have kidney disease (dose adjustment required)\nYou have heart failure\nYou are pregnant or planning to become pregnant\nYou are breastfeeding\n\nImportant Patient Information\nMonitoring: Regular monitoring of blood glucose levels and HbA1c testing (typically every 3-6 months) is essential to assess treatment effectiveness and make necessary adjustments.\nLifestyle Factors: GLISITAPTIN 100 works best when combined with a healthy diet, regular physical activity, and weight management. Medication alone cannot substitute for comprehensive lifestyle management.\nMissed Dose: If you miss a dose, take it as soon as you remember on the same day. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Never double up doses.\nStorage: Store GLISITAPTIN 100 at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.\nDrug Interactions\nGLISITAPTIN 100 has few significant drug interactions, contributing to its safety profile. However, inform your healthcare provider about all medications, supplements, and herbal products you're taking. Particular attention should be paid to:\n\nOther diabetes medications (may require dose adjustments)\nDigoxin (levels may be slightly increased)\nMedications affecting kidney function\n\nConclusion\nGLISITAPTIN 100 (Sitagliptin Phosphate 100 mg) represents a modern, effective, and well-tolerated option for managing type 2 diabetes mellitus. Its innovative mechanism through the incretin system offers multiple advantages including effective glucose control, low hypoglycemia risk, weight neutrality, and once-daily convenience. These benefits make it an excellent choice for many patients, whether used alone or in combination with other antidiabetic medications.", "price": 464.0, "discountamount": 139.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2272, "imageuri": "https://productimages.withfloats.com/actual/6961f2c8ba33389b8e9f0122.png", "tileimageuri": "https://productimages.withfloats.com/tile/6961f2c8ba33389b8e9f0122.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-10T06:33:41.727Z", "updatedon": "2026-03-13T05:59:37.431Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-phosphate-100-mg/2272", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLISITAPTIN 100", "category": "DIABETIC RANGE", "tags": [ "sitagliptin phosphate 100 mg tablet uses", "sitagliptin phosphate 100 mg dosage", "sitagliptin phosphate 100 mg side effects", "sitagliptin phosphate 100 mg benefits", "sitagliptin phosphate 100 mg price in india", "sitagliptin phosphate tablets 100 mg", "what is sitagliptin phosphate 100 mg used for", "how sitagliptin phosphate works in diabetes", "sitagliptin phosphate 100 mg for type 2 diabetes", "sitagliptin phosphate 100 mg mechanism of action", "sitagliptin phosphate tablet how to take", "medicine to control blood sugar sitagliptin", "tablet for post meal blood sugar control", "sitagliptin phosphate for high blood sugar", "can sitagliptin phosphate cause weight gain" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69184bfede5d3e57a933eff1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glipizide Tablets ip 5mg", "description": "GLIPIDIAB 5 is an oral antidiabetic medication containing Glipizide 5 mg, which belongs to the class of drugs known as sulfonylureas. It is widely prescribed for individuals with Type 2 Diabetes Mellitus (T2DM) to help control blood sugar levels when diet and lifestyle measures alone are not sufficient. GLIPIDIAB 5 works by stimulating the pancreas to produce more insulin and enhancing the body’s ability to utilize that insulin effectively.\n\nAs Type 2 diabetes often progresses over time, the pancreas gradually produces less insulin. GLIPIDIAB 5 helps bridge that gap by promoting insulin secretion, thereby lowering elevated fasting and post-meal blood glucose levels. It is usually taken once daily before meals, although dosage and frequency vary depending on a doctor’s evaluation of the patient’s condition.\n\nGLIPIDIAB 5 is often used alone or in combination with other antidiabetic medications such as metformin, DPP-4 inhibitors, or insulin, depending on the severity of blood sugar imbalance. Its predictable glucose-lowering effect makes it a long-standing and reliable treatment option in diabetes care.\n\nUses of GLIPIDIAB 5\n\nGLIPIDIAB 5 is primarily used for:\n\n1. Management of Type 2 Diabetes Mellitus\n\nIts main role is to help lower high blood glucose levels in adults diagnosed with T2DM. By improving insulin secretion, it helps maintain smoother and more stable sugar control throughout the day.\n\n2. Prevention of Diabetes-Related Complications\n\nMaintaining blood sugar within the target range reduces the risk of long-term complications such as:\n\nNerve damage (neuropathy)\n\nKidney disease (nephropathy)\n\nEye problems (retinopathy)\n\nCardiovascular diseases\n\nPoor wound healing\n\n3. Supporting Comprehensive Diabetes Treatment Plans\n\nGLIPIDIAB 5 is often part of a broader diabetes management plan that includes diet adjustment, physical activity, and regular monitoring of glucose levels.\n\nKey Benefits of GLIPIDIAB 5\n1. Effective Blood Sugar Reduction\n\nGLIPIDIAB 5 works quickly and efficiently to reduce blood sugar by boosting insulin release, making it effective for controlling both fasting and meal-related spikes in glucose.\n\n2. Long-Established Safety and Reliability\n\nGlipizide has been used in diabetes treatment for decades, with well-understood actions and predictable results. Its long history makes it a trusted choice among healthcare professionals.\n\n3. Convenient Once-Daily Dosing\n\nMost patients take the medicine once daily before breakfast, making it simple and easy to incorporate into a daily routine.\n\n4. Can Be Combined with Other Antidiabetic Medicines\n\nGLIPIDIAB 5 works well with other medications, especially when blood sugar control requires a multi-drug approach.\n\n5. Helps Reduce Future Health Risks\n\nBy maintaining controlled sugar levels, GLIPIDIAB 5 contributes to reducing the risk of serious long-term diabetes complications and enhances overall quality of life.\n\nPossible Side Effects\n\nLike all medications, GLIPIDIAB 5 may cause side effects. These vary among individuals and may include:\n\nCommon Side Effects\n\nLow blood sugar (hypoglycemia)—symptoms include sweating, dizziness, hunger, trembling, or palpitations\n\nNausea or stomach discomfort\n\nHeadache\n\nMild skin reactions such as rash or itching\n\nLess Common but Serious Side Effects\n\nSevere hypoglycemia, especially if meals are skipped or excessive insulin is produced\n\nLiver-related issues (rare)\n\nAllergic reactions such as swelling or severe skin redness\n\nBlood disorders like anemia (rare)\n\nTo reduce the risk of low blood sugar, regular meals and proper monitoring are important.\n\nConclusion\n\nGLIPIDIAB 5 is a proven and effective medication for managing Type 2 diabetes, particularly in patients who need additional insulin stimulation to maintain normal blood sugar levels. By enhancing natural insulin production and helping prevent long-term diabetes complications, it plays a vital role in comprehensive diabetes care. While it offers significant benefits, it must be used responsibly under medical supervision, especially because of its potential to cause low blood sugar. With consistent use, lifestyle adjustments, and regular monitoring, GLIPIDIAB 5 can greatly contribute to stable glucose control and improved overall health for individuals living with Type 2 diabetes.", "price": 15.0, "discountamount": 5.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2207, "imageuri": "https://productimages.withfloats.com/actual/69184c00c1423dc102d9e723.png", "tileimageuri": "https://productimages.withfloats.com/tile/69184c00c1423dc102d9e723.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-15T09:46:38.169Z", "updatedon": "2026-03-13T10:43:35.971Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glipizide-tablets-ip-5mg/2207", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIPIDIAB 5", "category": "DIABETIC RANGE", "tags": [ "type 2 diabetes mellitus (T2DM) help control blood sugar levels", "help control blood sugar levels", "Supporting Comprehensive Diabetes Treatment Plans", "insulin production and helping prevent long-term diabetes ." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }